NEUROPROTECTION AND MYELIN REPAIR USING NESTORONE
Methods for treating neurodegeneration and/or myelination in patients are disclosed comprising treating the patient with a progestin compound which exerts binding to progesterone receptors and elicits progesterone-receptor-induced biological responses without interacting with the androgen receptor a...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
13.09.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Methods for treating neurodegeneration and/or myelination in patients are disclosed comprising treating the patient with a progestin compound which exerts binding to progesterone receptors and elicits progesterone-receptor-induced biological responses without interacting with the androgen receptor and without inducing androgen or glucocorticoid biological responses at a dosage sufficient to prevent or reduce neurodegeneration. The progestin compound preferably comprises 16-methylene-17α-acetoxy-19-norpregn-4-ene-3,20-dione, and the methods include combining the progestin compound with an estrogen compound to provide both contraception and treatment for myelin repair and neurodegeneration. |
---|---|
Bibliography: | Application Number: US201013500008 |